Ecliptasaponin D has been shown to have an inhibitory effect on tumor necrosis factor-α (TNF-α) and matrix metalloproteinases by inhibiting the release of these proinflammatory cytokines from immune cells.
Molecular Weight
634.84
Molecular Formula
C36H58O9
Form
Light gray powder
Purity
>98%, determined by HPLC.
Identity
Confirmed by NMR and MS.
Applications
Ecliptasaponin D can be used for increasing mitochondrial membrane potential and decreasing reactive oxygen species production.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
